These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 15592697

  • 1. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
    Nose T, Peiffert D, Lapeyre M, Hoffstetter S, Koizumi M, Nishiyama K.
    Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697
    [Abstract] [Full Text] [Related]

  • 2. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

  • 3. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 4. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):696-705. PubMed ID: 15183473
    [Abstract] [Full Text] [Related]

  • 5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S.
    Brachytherapy; 2006 Jul 01; 5(1):49-55. PubMed ID: 16563997
    [Abstract] [Full Text] [Related]

  • 6. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Rojpornpradit P, Chottetanaprasith T, Srisuthep A, Suriyapee S, Jumpangern C, Tresukosol D, Charoonsantikul C.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1424-31. PubMed ID: 15275728
    [Abstract] [Full Text] [Related]

  • 7. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
    Takácsi-Nagy Z, Polgár C, Oberna F, Somogyi A, Major T, Remenár E, Fodor J, Kásler M, Németh G.
    Strahlenther Onkol; 2004 Dec 01; 180(12):768-75. PubMed ID: 15592696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H, Pötter R, Knocke TH, Baldass M, Kucera E.
    Wien Klin Wochenschr; 2001 Jan 15; 113(1-2):58-62. PubMed ID: 11233470
    [Abstract] [Full Text] [Related]

  • 11. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R.
    Radiat Oncol Investig; 1997 Jan 15; 5(6):289-99. PubMed ID: 9436246
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E, Oh RJ, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, Teshima T, Inoue T, Inoue T.
    Brachytherapy; 2003 Jan 15; 2(2):85-90. PubMed ID: 15062145
    [Abstract] [Full Text] [Related]

  • 13. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients.
    Nose T, Koizumi M, Nishiyama K.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):983-91. PubMed ID: 15234031
    [Abstract] [Full Text] [Related]

  • 14. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 15. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
    Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):480-4. PubMed ID: 17141980
    [Abstract] [Full Text] [Related]

  • 16. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, Hanson W, Wilenzick RM.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):45-51. PubMed ID: 16503383
    [Abstract] [Full Text] [Related]

  • 18. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P, Dietrich J, Ostertag H, Schmid A, Kohr P, Kimmig B, Kovács G.
    Strahlenther Onkol; 2006 Feb 01; 182(2):102-7. PubMed ID: 16447017
    [Abstract] [Full Text] [Related]

  • 19. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1444-50. PubMed ID: 16029806
    [Abstract] [Full Text] [Related]

  • 20. Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix.
    Patel FD, Kumar P, Karunanidhi G, Sharma SC, Kapoor R.
    Brachytherapy; 2011 Aug 01; 10(2):147-53. PubMed ID: 20685179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.